We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $3.11B
1-Year Est. Return 94.93%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$5.88B
AUM Growth
+$1.12B
Cap. Flow
+$891M
Cap. Flow %
15.14%
Top 10 Hldgs %
56.13%
Holding
64
New
10
Increased
8
Reduced
7
Closed
13

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$290M
2
BID
Sotheby's
BID
+$141M
3
AGN
Allergan plc
AGN
+$96.9M
4
ARRY
Array Biopharma Inc
ARRY
+$92M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$81.8M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$82.7M
2
TVPT
Travelport Worldwide Limited
TVPT
+$51.9M
3
RHT
Red Hat Inc
RHT
+$42.4M
4
AABA
Altaba Inc
AABA
+$33.8M
5
FOX icon
Fox Class B
FOX
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.76%
2 Materials 9.86%
3 Communication Services 8.7%
4 Technology 5.01%
5 Financials 4.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$129B
$575M 9.78%
4,320,022
– –
BHC icon
2
Bausch Health
BHC
$1.75B
$526M 8.93%
20,839,035
– –
AGN
3
DELISTED
Allergan plc
AGN
$377M 6.4%
2,249,500
+700,000
+45% +$96.9M
DISCK
4
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$311M 5.28%
10,922,500
– –
CELG
5
DELISTED
Celgene Corp
CELG
$310M 5.26%
3,350,000
+50,000
+2% +$4.75M
APC
6
DELISTED
Anadarko Petroleum
APC
$305M 5.18%
+4,320,000
New +$290M
TAK icon
7
Takeda Pharmaceutical
TAK
$54.4B
$234M 3.98%
13,244,711
– –
AAMI
8
Acadian Asset Management
AAMI
$2.93B
$228M 3.88%
20,000,552
– –
AU icon
9
AngloGold Ashanti
AU
$37.9B
$228M 3.87%
12,782,400
– –
VTRS icon
10
Viatris
VTRS
$19.8B
$210M 3.56%
11,005,400
– –
BID
11
DELISTED
Sotheby's
BID
$196M 3.33%
+3,367,800
New +$141M
DISH
12
DELISTED
DISH Network Corp.
DISH
$191M 3.25%
4,973,500
– –
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
$168M 2.85%
587,700
+272,800
+87% +$75.2M
GDX icon
14
PUT
VanEck Gold Miners ETF
GDX
$21.6B
$166M 2.82%
6,500,000
+6,200,000
+2,067% +$137M
LYFT icon
15
Lyft
LYFT
$5.86B
$163M 2.77%
2,477,570
– –
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$160M 2.73%
6,670,700
– –
ARRY
17
DELISTED
Array Biopharma Inc
ARRY
$152M 2.58%
+3,275,700
New +$92M
TMUS icon
18
T-Mobile US
TMUS
$212B
$145M 2.46%
1,955,600
– –
AABA
19
DELISTED
Altaba Inc
AABA
$132M 2.24%
1,900,163
-482,400
-20% -$33.8M
NG icon
20
NovaGold Resources
NG
$2.29B
$130M 2.21%
21,992,896
– –
TSLA icon
21
PUT
Tesla
TSLA
$1.39T
$120M 2.04%
+8,047,500
New +$125M
ONCE
22
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$77.6M 1.32%
+757,807
New +$81.8M
TIMB icon
23
TIM SA
TIMB
$10.6B
$74.8M 1.27%
5,000,000
– –
PCG icon
24
PG&E
PCG
$38.4B
$68.8M 1.17%
+3,000,810
New +$60.3M
S
25
DELISTED
Sprint Corporation
S
$52.6M 0.89%
8,000,000
+4,885,100
+157% +$30.9M
1
2 3

Similar funds

TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return

Paulson & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Paulson & Co held 64 positions worth $5.88B, up 23% from $4.76B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Paulson & Co deployed $891M of net new capital in Q2 2019, opening 10 new positions and adding to 8 existing holdings. Its largest new stake was Anadarko Petroleum: 4,320,000 shares worth $305M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 41% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Red Hat Inc, an estimated $42.4M trimmed.

  • Paulson & Co's largest Q2 2019 buy was Anadarko Petroleum: 4,320,000 shares worth $305M.
  • Paulson & Co added most to Allergan plc in Q2 2019, an estimated $96.9M increase.
  • Paulson & Co's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $42.4M.
  • Paulson & Co fully exited Centene in Q2 2019, selling an estimated $82.7M.
  • Paulson & Co's ten largest holdings make up 56% of its $5.88B portfolio in Q2 2019.
  • Paulson & Co opened 10 new positions and closed 13 in Q2 2019.
  • Paulson & Co's portfolio value rose 23% quarter-over-quarter to $5.88B.

Based on Paulson & Co's 13F filing for Q2 2019, filed 14 Aug 2019.